An observational study in Diabetic Neuropathy With Neurologic Complication, sponsored by Vagus Nerve Society. Completed at 1 site in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2025-06-17.
Sponsored by Vagus Nerve Society · Observational
This is an observational study that will follow patients in the course of routine care and measure pain levels, glucose assessments and drug utilization for native American patients with diabetic neuropathy
Patients with diabetic neuropathy pain will have an NS100 device implanted for chronic diabetic neuropathy pain consistent with onlabel indication. All patients will be followed for 90 days post implant to measure improvements in pain, drug utilization and glucose levels.
1,003 studies on the registry are indexed under Peripheral Nervous System Diseases; 177 are open to participants now.
This study's enrollment of 83 is close to the median of 90 across 188 observational studies indexed under Peripheral Nervous System Diseases.
Browse Peripheral Nervous System Diseases studies →This is the only study on the registry with Vagus Nerve Society as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Native American Population with Diabetic Neuropathy pain
Exclusion Criteria
Use of Trigeminal Vagus cervical nerve stimulation for diabetic neuropathy pain
Drug: Implantation of a trigeminal Vagus cervical nerve stimulator system · Device: Implantation of a neurostimulator system for trigeminal vagal cervical nerve stimulation
The NS 100 is a medical device used for the treatment of diabetic neuropathy pain. Routine observational monitoring will be performed
The medium term outcomes of neurostimulation will be assessed on diabetic neuropathy pain, glucose and drug usage
Pain scores over time
Periodic pain scores will be measured for 90 days and possibly longer
Time frame: 90 days
glucose levels will be measured over time
Serum glucose levels will be followed on patients receiving neurostimulation
Time frame: 90 days
Plan to share: No — Want to maintain patient autonomy
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peripheral Nervous System Diseases→